PowerUp enters additional non-redemption deals covering 1.5M shares ahead of extension vote

Aspire Biopharma Holdings, Inc.

Non-redemption agreements with unaffiliated third parties on May 9 and May 12, 2023 covering 1,500,000 Class A shares.
In exchange, Sponsor transfers 750,000 Class B shares to those investors after a business combination.
Shares remain in trust after Extraordinary General Meeting; extension proposal seeks to push deadline to May 2024.
Agreements are not expected to affect approval likelihood but will increase trust account funds.

Key facts

Extracted from this filing and checked against the source text.

Material Agreements SEC 8-K Item 1.01/1.02 confidence 0.9

Aspire Biopharma Holdings, Inc. entered into Non-Redemption Agreements with certain unaffiliated third parties (effective 2023-05-09).

Action: entry
Counterparty: certain unaffiliated third parties
Effective: 2023-05-09

Exact text from the filing

On May 9, 2023 and May 12, 2023, the Sponsor and the Company entered into additional Non-Redemption Agreements with additional unaffiliated third parties.

View on SEC.gov

281 material agreements filed in the last 30 days. Browse all material agreements →

Aspire Biopharma Holdings, Inc. filing history →

Source: SEC EDGAR

accession 0001104659-23-060945

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.